Lightcalls.com
 

If you're in the temper for romanti...

If you're in the temper for romantic fiction, allow me to recommend the many Web sites where family describe their own wonderfulness in waiting under the possibility of fulfilments that other people of equal wonderfulnes will court them out for companionship. one time both parties discover that they're chief part mates, they will snuggle, take in extent walks on the beach and have sexual delight with each other's sense of humor happily forever after. At least, that's the implied promise.

Given the generosity with which race describe themselves, such Web sites are an embarrassment of riches. There's not a selfish, insatiable spiteful or narcissistic human being among the knob Instead, everyone is sensitive (in the spirit of the age), ready for a strange adventure (read: I'm not doing anything nearest Saturday) and further self-described at limitless other adjectives (kind, loving, as good as one's word sincere, etc.).

This brings me around to claims for certain dietary continuations If you believe what single in kind Internet purveyor of coral calcium has been saying, its brand of CC is perfection itself. Not and nothing else is it good for bone and teeth moreover it cures heart disease, interrupts cancer and adds 30 happy years to your life. (In common testimonial, a woman reported CC cleared up her mother's Alzheimer's condition, in such a manner logically, the woman decided CC also would be a benefaction for her Maltese dog.)



Consumer should be suspicious of dietary continuations that promise more than objective evidence--or universal sense--allows. In this issue, we intimate types of supplements good for injuries caused from physical exertion (see "Nature Heals," p 26) We're satisfied that the claims for each are reasonably justified. however even though glucosamine, to pick an example, will relieve knee joint soreness, it won't obstruct a broken leg. When the original purports of a natural substance are exaggerated into falsity, consumer have the right to wait for government intervention, as has happened with one as well as the other CC and ephedra sold onward the Net.

And that's wherefore in our editors' view, conventional science is the merely means of separating the credible from the bogus--and is more than a match for the world's charlatans.

COPYRIGHT 2003 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved

COPYRIGHT 2003 Gale Group



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.